Skip to main content
Caplight Logo









Wuhan Bio-Raid Biotechnology

Wuhan Bio-Raid Biotechnology

Private
WuhanHealthcare & Life Scienceshttps://bio-raid.com

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Wuhan Bio-Raid Biotechnology operates in Healthcare & Life Sciences and is based in Wuhan. It was founded in 2014.

Wuhan Bio-Raid Biotechnology is a biotechnology company that develops CAR-T cell immunotherapy for the treatment of blood tumors, solid tumors, and viral infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Wuhan Bio-Raid Biotechnology Comparables

Compare Wuhan Bio-Raid Biotechnology with similar companies based on industry and business-model similarity.

Wuhan Bio-Raid Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shanghai Unicar-Therapy Bio-medicine Technology
88%
Chongqing Precision Biotech Co., Ltd.
88%
Shanghai YaKe Biotechnology Co., Ltd.
87%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Wuhan Bio-Raid Biotechnology Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Wuhan Bio-Raid Biotechnology. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors increased 547% MoM.

  • Feb 2, 2026

    Monthly visitors grew 320% MoM, reaching 1.1K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Wuhan Bio-Raid Biotechnology Filings

Explore SEC and related filing metadata, where available.

Wuhan Bio-Raid Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Wuhan Bio-Raid Biotechnology's valuation, stock price, and market status.

Is Wuhan Bio-Raid Biotechnology a public or private company?

Wuhan Bio-Raid Biotechnology is a private company.

What is the current stock price of Wuhan Bio-Raid Biotechnology?

Wuhan Bio-Raid Biotechnology is a private company, so its shares have no public market price. Caplight tracks Wuhan Bio-Raid Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Wuhan Bio-Raid Biotechnology worth (valuation)?

Valuation information for Wuhan Bio-Raid Biotechnology is not publicly available.

Can I buy Wuhan Bio-Raid Biotechnology stock?

Wuhan Bio-Raid Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Wuhan Bio-Raid Biotechnology's last funding round?

Funding round information for Wuhan Bio-Raid Biotechnology is not publicly available.

Who are the main investors in Wuhan Bio-Raid Biotechnology?

Investor information for Wuhan Bio-Raid Biotechnology is not publicly disclosed.

Will Wuhan Bio-Raid Biotechnology IPO soon?

No public IPO plans have been announced for Wuhan Bio-Raid Biotechnology.

How can I track Wuhan Bio-Raid Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades in Wuhan Bio-Raid Biotechnology's shares on secondary markets.

Firmographic Details

HeadquartersWuhan
Employee Range2
Year Founded2014
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?